Correlation Between Pfizer and RESAAS Services

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and RESAAS Services at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and RESAAS Services into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and RESAAS Services, you can compare the effects of market volatilities on Pfizer and RESAAS Services and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of RESAAS Services. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and RESAAS Services.

Diversification Opportunities for Pfizer and RESAAS Services

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Pfizer and RESAAS is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and RESAAS Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RESAAS Services and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with RESAAS Services. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RESAAS Services has no effect on the direction of Pfizer i.e., Pfizer and RESAAS Services go up and down completely randomly.

Pair Corralation between Pfizer and RESAAS Services

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.25 times more return on investment than RESAAS Services. However, Pfizer Inc is 3.98 times less risky than RESAAS Services. It trades about 0.09 of its potential returns per unit of risk. RESAAS Services is currently generating about -0.02 per unit of risk. If you would invest  2,270  in Pfizer Inc on May 12, 2025 and sell it today you would earn a total of  188.00  from holding Pfizer Inc or generate 8.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  RESAAS Services

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in September 2025.
RESAAS Services 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days RESAAS Services has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pfizer and RESAAS Services Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and RESAAS Services

The main advantage of trading using opposite Pfizer and RESAAS Services positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, RESAAS Services can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RESAAS Services will offset losses from the drop in RESAAS Services' long position.
The idea behind Pfizer Inc and RESAAS Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments